IR/PR

2021.03.30

2021.03.25

2021.03.24

InnoTherapy, selected as a research institute for the development of Reference Materials for gene therapy by the K-MFDS

2020.12.09

Finemedix Co., Ltd., InnoTherapy’s strategic partner, challenge for IPO with ‘Localization of endoscope’

2020.12.08

InnoTherapy, Challenge to new bio medicines… Review of establishment of subsidiary

2020.11.07

InnoTherapy, Selected as “National Innovation Company 1000”

2020.05.25

Two Korean conglomerates which acted as incubators of start-up ventures that lead K-Bio: Samsung for medical devices, LG for new drugs

2020.05.04

InnoTherapy’s patent regarding catecholamine… is registered in India

2020.02.17

New hemostat based on technology that mimics the thread of mussels… “Anticipated to be a game changer in the field of hemostats”

2020.01.21

InnoTherapy plans to develop a next-generation drug delivery system

2020.02.23

InnoTherapy & FineMedics: Co-development of liquid Hemostat as an endoscopy solution

2019.12.26

Approval of EndoSil by K-MFDS

2019.12.18

Registration of the patent regarding hemostatic needle

2019.10.17

Partnership with NVC and bio-venture investment

2019.10.10

Approval of InnoSeal Plus by K-MFDS